BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 30255656)

  • 1. Knockdown of PEBP4 inhibits human glioma cell growth and invasive potential via ERK1/2 signaling pathway.
    Huang RQ; Wang SQ; Zhu QB; Guo SC; Shi DL; Chen F; Fang YC; Chen R; Lu YC
    Mol Carcinog; 2019 Jan; 58(1):135-143. PubMed ID: 30255656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased expression of phosphatidylethanolamine-binding protein 4 (PEBP4) strongly associates with human gliomas grade.
    Huang RQ; Shi DL; Huang W; Chen F; Lu YC
    J Neurooncol; 2016 Apr; 127(2):235-42. PubMed ID: 26725095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-423-5p contributes to a malignant phenotype and temozolomide chemoresistance in glioblastomas.
    Li S; Zeng A; Hu Q; Yan W; Liu Y; You Y
    Neuro Oncol; 2017 Jan; 19(1):55-65. PubMed ID: 27471108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PEBP4 enhanced HCC827 cell proliferation and invasion ability and inhibited apoptosis.
    Yu G; Shen Z; Chen G; Teng X; Hu Y; Huang B
    Tumour Biol; 2013 Feb; 34(1):91-8. PubMed ID: 22983920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CBX3 promotes glioma U87 cell proliferation and predicts an unfavorable prognosis.
    Zhao SP; Wang F; Yang M; Wang XY; Jin CL; Ji QK; Li S; Zhao XL
    J Neurooncol; 2019 Oct; 145(1):35-48. PubMed ID: 31502042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-383 expression regulates proliferation, migration, invasion, and apoptosis in human glioma cells.
    Xu D; Ma P; Gao G; Gui Y; Niu X; Jin B
    Tumour Biol; 2015 Sep; 36(10):7743-53. PubMed ID: 25936342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of SIRT6 by miR-33a facilitates tumor growth of glioma through apoptosis and oxidative stress resistance.
    Chang M; Qiao L; Li B; Wang J; Zhang G; Shi W; Liu Z; Gu N; Di Z; Wang X; Tian Y
    Oncol Rep; 2017 Aug; 38(2):1251-1258. PubMed ID: 28677777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silencing of CDCA5 inhibits cancer progression and serves as a prognostic biomarker for hepatocellular carcinoma.
    Wang J; Xia C; Pu M; Dai B; Yang X; Shang R; Yang Z; Zhang R; Tao K; Dou K
    Oncol Rep; 2018 Oct; 40(4):1875-1884. PubMed ID: 30015982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the PEBP4 protein in the development and metastasis of gastric cancer.
    Wu Z; Liu B; Zheng X; Hou H; Li Y
    Oncotarget; 2017 Mar; 8(11):18177-18184. PubMed ID: 28193908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown of PEBP4 suppresses proliferation, migration and invasion of human breast cancer cells.
    Wang SC; Zhou F; Zhou ZY; Hu Z; Chang L; Ma MD
    Biomed Pharmacother; 2017 Jun; 90():659-664. PubMed ID: 28415045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRAIL induces proliferation of human glioma cells by c-FLIPL-mediated activation of ERK1/2.
    Vilimanovich U; Bumbasirevic V
    Cell Mol Life Sci; 2008 Mar; 65(5):814-26. PubMed ID: 18239851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The novel chromatin architectural regulator SND1 promotes glioma proliferation and invasion and predicts the prognosis of patients.
    Yu L; Xu J; Liu J; Zhang H; Sun C; Wang Q; Shi C; Zhou X; Hua D; Luo W; Bian X; Yu S
    Neuro Oncol; 2019 Jun; 21(6):742-754. PubMed ID: 30753603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silencing of human phosphatidylethanolamine-binding protein 4 sensitizes breast cancer cells to tumor necrosis factor-alpha-induced apoptosis and cell growth arrest.
    Wang X; Li N; Li H; Liu B; Qiu J; Chen T; Cao X
    Clin Cancer Res; 2005 Oct; 11(20):7545-53. PubMed ID: 16243830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased SPK1 expression promotes cell growth by activating the ERK1/2 signaling in non-small-cell lung cancer.
    Yang Y; Zhao J; Hao D; Wang X; Wang T; Li H; Lv B
    Anticancer Drugs; 2019 Jun; 30(5):458-465. PubMed ID: 30920400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA GAS5 regulates the proliferation, migration, invasion and apoptosis of brain glioma cells through targeting GSTM3 expression. The effect of LncRNA GAS5 on glioma cells.
    Li G; Cai Y; Wang C; Huang M; Chen J
    J Neurooncol; 2019 Jul; 143(3):525-536. PubMed ID: 31172354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PEBP4 silencing inhibits hypoxia-induced epithelial-to-mesenchymal transition in prostate cancer cells.
    Li W; Dong Y; Zhang B; Kang Y; Yang X; Wang H
    Biomed Pharmacother; 2016 Jul; 81():1-6. PubMed ID: 27261570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockdown of hnRNP A2/B1 inhibits cell proliferation, invasion and cell cycle triggering apoptosis in cervical cancer via PI3K/AKT signaling pathway.
    Shi X; Ran L; Liu Y; Zhong SH; Zhou PP; Liao MX; Fang W
    Oncol Rep; 2018 Mar; 39(3):939-950. PubMed ID: 29328485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lentivirus mediated γ-interferon-inducible lysosomal thiol reductase (GILT) knockdown suppresses human glioma U373MG cell proliferation.
    Chen S; Wang Q; Shao X; Di G; Dai Y; Jiang X; Cheng L
    Biochem Biophys Res Commun; 2019 Jan; 509(1):182-187. PubMed ID: 30587343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LRRC4 inhibits human glioblastoma cells proliferation, invasion, and proMMP-2 activation by reducing SDF-1 alpha/CXCR4-mediated ERK1/2 and Akt signaling pathways.
    Wu M; Chen Q; Li D; Li X; Li X; Huang C; Tang Y; Zhou Y; Wang D; Tang K; Cao L; Shen S; Li G
    J Cell Biochem; 2008 Jan; 103(1):245-55. PubMed ID: 17549698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRAF-activated LncRNA functions as a tumor suppressor in papillary thyroid cancer.
    Liao T; Qu N; Shi RL; Guo K; Ma B; Cao YM; Xiang J; Lu ZW; Zhu YX; Li DS; Ji QH
    Oncotarget; 2017 Jan; 8(1):238-247. PubMed ID: 27462868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.